Evidence map›Paper›PMID 30879211›Full record

ArticleAIDS and behavior2019

Physician Mistrust, Medical System Mistrust, and Perceived Discrimination: Associations with HIV Care Engagement and Viral Load.

Ahnalee M Brincks, Karen Shiu-Yee, Lisa R Metsch, Carlos Del Rio, Robert P Schwartz, Petra Jacobs, Georgina Osorio, James L Sorensen, Daniel J Feaster

Abstract read
In one paragraph

Article in AIDS and behavior, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 57 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Exploring Willingness to Use Long-Acting Injectable PrEP Among Sexual and Gender Minoritized People Accessing Pharmacies.AIDS education and prevention : official publication of the International Society for AIDS Education · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Observational
  20. Diversity in Digital Pill Systems: Differences in Perceptions and Attitudes Towards Use of a Digital Pill System for HIV Pre-Exposure Prophylaxis Among Men Who Have Sex with Men with Diverse Racial and Ethnic Identities.Proceedings of the ... Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 1 country.

Ahnalee M BrincksDepartment of Epidemiology and Biostatistics, Michigan State University, 909 Wilson Road, East Lansing, MI, USA. brincksa@msu.edu.ORCID http://orcid.org/0000-0002-5049-1229
Karen Shiu-YeeDepartment of Sociomedical Sciences, Columbia University, New York, NY, USA.
Lisa R MetschDepartment of Sociomedical Sciences, Columbia University, New York, NY, USA.
Carlos Del RioDepartment of Global Health, Emory University, Atlanta, GA, USA.
Robert P SchwartzFriends Research Institute, Baltimore, MD, USA.
Petra JacobsNational Institute on Drug Abuse, Bethesda, MD, USA.
Georgina OsorioIcahn School of Medicine at Mount Sinai, New York, NY, USA.
James L SorensenDepartment of Psychiatry at the University of California San Francisco, San Francisco, CA, USA.
Daniel J FeasterDepartment of Public Health Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.
Columbia University · USEmory University · USFriends Research Institute · USIcahn School of Medicine at Mount Sinai · USMichigan State University · USNational Institute on Drug Abuse · USUniversity of California, San Francisco · USUniversity of Miami · US

Funding

Project-003UG1DA013035 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Aimee N Campbell, Jennifer McNeely · 2015 to 2026
$130.3M
The National Drug Abuse Treatment Clinical Trials NetworkUG1DA015831 · NIDA · YALE UNIVERSITY · PI Gail D'Onofrio, Roger D. Weiss · 2015 to 2026
$110.8M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Carlos del Rio · 2002 to 2026
$74.0M
Project-004UG1DA020024 · NIDA · UT SOUTHWESTERN MEDICAL CENTER · PI Steven J Shoptaw, MADHUKAR H. TRIVEDI · 2015 to 2026
$71.6M
FLORIDA NODE OF THE DRUG ABUSE CLINICAL TRIALS NETWORKU10DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI METSCH, LISA R, SZAPOCZNIK, JOSE · 2000 to 2015
$56.9M
The National Drug Abuse Treatment Clinical Trials NetworkU10DA013045 · NIDA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LING, WALTER NMN · 1999 to 2015
$52.6M
The Florida Node Alliance of the National Drug Abuse Treatment Clinical Trials NetworkUG1DA013720 · NIDA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Daniel J Feaster, Viviana Elizabeth Horigian · 2015 to 2026
$50.6M
CU PARTNERS: NY/LONG ISLAND REGIONAL NODEU10DA013035 · NIDA · NEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC · PI NUNES, EDWARD V., ROTROSEN, JOHN P · 2001 to 2015
$47.6M
Clinical Trials Network, Ohio Valley Node U10DA013732U10DA013732 · NIDA · UNIVERSITY OF CINCINNATI · PI WINHUSEN, T JOHN · 2000 to 2015
$45.0M
The Ohio Valley Node of the Clinical Trials Network (CTN-0153)UG1DA013732 · NIDA · UNIVERSITY OF CINCINNATI · PI T John WINHUSEN · 2015 to 2026
$42.5M
Southern Consortium Node of the Clinical Trials NetworkU10DA013727 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2000 to 2015
$34.4M
The National Drug Abuse Treatment Clinical Trials Network (U10)U10DA015831 · NIDA · MC LEAN HOSPITAL (BELMONT, MA) · PI CARROLL, KATHLEEN M., WEISS, ROGER D. · 2002 to 2015
$28.8M
Foundation for the National Institutes of Health P30AI050409NIAID NIH HHS P30 AI050409NIDA NIH HHS R01 DA041063NIDA NIH HHS T32 DA037801NIDA NIH HHS T32-DA037801NIDA NIH HHS U10 DA013034NIDA NIH HHS U10DA013034NIDA NIH HHS U10 DA013035NIDA NIH HHS U10DA013035NIDA NIH HHS U10 DA013043NIDA NIH HHS U10 DA013045NIDA NIH HHS U10 DA013720NIDA NIH HHS U10DA013720NIDA NIH HHS U10 DA013727NIDA NIH HHS U10 DA013732NIDA NIH HHS U10 DA015815NIDA NIH HHS U10DA015815NIDA NIH HHS U10 DA015831NIDA NIH HHS U10 DA020024NIDA NIH HHS U10DA020024NIDA NIH HHS U10 DA020036NIDA NIH HHS UG1 DA013034NIDA NIH HHS UG1 DA013035NIDA NIH HHS UG1 DA013720NIDA NIH HHS UG1 DA013727NIDA NIH HHS UG1 DA013732NIDA NIH HHS UG1 DA015815NIDA NIH HHS UG1 DA015831NIDA NIH HHS UG1 DA020024
6 · The paper itself

Abstract

Medical mistrust is an important risk factor for many health outcomes. For individuals with HIV and substance use co-morbidities, mistrust may influence engagement with health care, and affect overall health and transmission risk. Medical mistrust can be measured by an individual's mistrust of his/her physician, or mistrust of the medical system. This study examined both types of mistrust among 801 substance-using individuals with uncontrolled HIV infection. The aims were to determine how physician mistrust, medical system mistrust, and discrimination experiences were associated with engagement in HIV primary care. Findings indicated higher levels of physician mistrust, but not medical system mistrust, were associated with a longer time since the last visit to an HIV provider. Longer time since seeing an HIV care provider was associated with higher viral load. This study refines our understanding of the relationship between mistrust and HIV care engagement for a large, diverse sample of substance-using individuals.

Indexed as

Social DiscriminationAdultAnti-Retroviral AgentsAttitude of Health PersonnelBlack or African AmericanDrug MonitoringFemaleHispanic or LatinoHIV InfectionsHumansMaleMedication AdherenceMiddle AgedPatient Acceptance of Health CareStereotypingSubstance-Related DisordersAnti-Retroviral AgentsDiscriminationHealth care engagementHIVMedical mistrust

Identifiers

PMID30879211
PMCPMC6854532
OpenAlexW2921346427

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.